(0)

DIA会员及用户请点击登录

登录

忘记用户 ID？ or 忘记密码？

Not a Member?

创建账户并加入。

Virtual Event

2024 年 04 月 12 日 1:00 下午 - 2024 年 04 月 12 日 5:30 下午

(Central Europe Standard Time)

4051 Basel, Switzerland

Transitioning Clinical Trials from Directive 2001/20/EC to Regulation (EU) 536/2014 via CTIS

TO MEET THE TIMELINE FOR PROCESSING THE APPLICATION, THE TRANSITION APPLICATION MUST BE SUBMITTED TO THE CTIS PORTAL BY 16 OCTOBER 2024! THIS IS YOUR LAST CHANCE to attend this live virtual training course and enhance your knowledge in managing transition applications in CTIS in all theoretical as well as practical aspects.

立即注册（信用卡）
CONTACT US
Send Email +41 61 225 51 51

概览

The transition period for the EU Regulation on clinical trials on medicinal products for human use is ending on 30 January 2025.

TO MEET THE TIMELINE FOR PROCESSING THE APPLICATION, THE TRANSITION APPLICATION MUST BE SUBMITTED TO THE CTIS PORTAL BY 16 OCTOBER 2024.

The live virtual training course aims to enhance knowledge in managing transition applications in CTIS.

Legal basis, regulatory and operational aspects of transitions will be explained. Practical case studies to manage the transition in CTIS will be demonstrated.

Participants will have the opportunity to ask questions in order to gain a comprehensive understanding of the CTIS transition activities required for compliance.

精选主题

    • Clinical trials in scope for transition
    • Documentation requirements
    • Sources of references and guidance
    • Timing of transition and planning considerations
    • Consolidating versus harmonizing dossier components
    • Product cross-reference and “IMPD-Q only” application concept
    • Master EMA database pre-conditions (IAM, OMS, XEVMPD)
    • Expected process (timelines, RFI/responses, substantial modification to complete transition dossier)
    • Initial transition application
    • Subsequent Substantial Modification (SM)
    • IMPD-Q only application scheme

    谁应该参加？

    This training course is intended for knowledgeable sponsor workspace users (commercial sponsors, academia, CROs), including SMEs wishing to enhance knowledge how to transition ongoing clinical trials authorized under the CT Directive to the EU CT Regulation via CTIS.

    学习目标

    • At the conclusion of this virtual live training course, participants will be able to:

      • Recognise the legal and regulatory aspects for transition
      • Develop a robust transition implementation strategy
      • Identify the transition application dossier components
      • Deploy the CTIS transition activities required for compliance

    Digital Learning Catalog

    DIA Learning: eLearning Soultions
    Download
    立即注册（信用卡）

    获得信息并保持参与

    不要错失任何机会——请加入我们的邮件列表，了解DIA的观点和事件。